Bessemer Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Sell |
200
-361
| -64% | -$9.03K | ﹤0.01% | 2001 |
|
|
2025
Q1 | $17K | Sell |
561
-488,069
| -100% | -$14.8M | ﹤0.01% | 1586 |
|
|
2024
Q4 | $18.1M | Buy |
488,630
+11,609
| +2% | +$431K | 0.03% | 268 |
|
|
2024
Q3 | $23.2M | Buy |
477,021
+10,793
| +2% | +$524K | 0.04% | 239 |
|
|
2024
Q2 | $18.6M | Buy |
466,228
+70,287
| +18% | +$2.81M | 0.03% | 255 |
|
|
2024
Q1 | $17.4M | Buy |
395,941
+69,968
| +21% | +$3.07M | 0.03% | 251 |
|
|
2023
Q4 | $20.2M | Buy |
325,973
+177,829
| +120% | +$11M | 0.04% | 220 |
|
|
2023
Q3 | $6.81M | Buy |
148,144
+147,824
| +46,195% | +$6.8M | 0.02% | 318 |
|
|
2023
Q2 | $18K | Buy |
320
+182
| +132% | +$10.2K | ﹤0.01% | 1534 |
|
|
2023
Q1 | $5K | Buy |
138
+24
| +21% | +$870 | ﹤0.01% | 1593 |
|
|
2022
Q4 | $3K | Hold |
114
| – | – | ﹤0.01% | 1704 |
|
|
2022
Q3 | $3K | Sell |
114
-48
| -30% | -$1.26K | ﹤0.01% | 1827 |
|
|
2022
Q2 | $6K | Hold |
162
| – | – | ﹤0.01% | 1465 |
|
|
2022
Q1 | $6K | Buy |
+162
| New | +$6K | ﹤0.01% | 1463 |
|
|
2020
Q3 | – | Sell |
-111,600
| Closed | -$2.51M | – | 1344 |
|
|
2020
Q2 | $2.51M | Hold |
111,600
| – | – | 0.01% | 426 |
|
|
2020
Q1 | $1.66M | Buy |
111,600
+900
| +0.8% | +$13.4K | 0.01% | 478 |
|
|
2019
Q4 | $2.14M | Buy |
110,700
+5,600
| +5% | +$108K | 0.01% | 546 |
|
|
2019
Q3 | $2.08M | Buy |
105,100
+6,600
| +7% | +$131K | 0.01% | 504 |
|
|
2019
Q2 | $2.08M | Sell |
98,500
-1,400
| -1% | -$29.5K | 0.01% | 522 |
|
|
2019
Q1 | $2.04M | Buy |
99,900
+29,400
| +42% | +$601K | 0.01% | 450 |
|
|
2018
Q4 | $1.4M | Buy |
70,500
+38,300
| +119% | +$762K | 0.01% | 493 |
|
|
2018
Q3 | $620K | Buy |
+32,200
| New | +$620K | ﹤0.01% | 703 |
|
|
2016
Q4 | – | Sell |
-9,400
| Closed | -$178K | – | 1930 |
|
|
2016
Q3 | $178K | Buy |
+9,400
| New | +$178K | ﹤0.01% | 996 |
|